C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma

被引:0
作者
Rosario S. Rivera
Hitoshi Nagatsuka
Mehmet Gunduz
Beyhan Cengiz
Esra Gunduz
Chong Huat Siar
Hidetsugu Tsujigiwa
Ryo Tamamura
Kok Ng Han
Noriyuki Nagai
机构
[1] Okayama University,Department of Oral Pathology and Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
[2] University of the East,College of Dentistry
[3] University of Malaya,Department of Oral Pathology, Oral Medicine and Periodontology, Faculty of Dentistry
[4] Institute for Medical Research,Unit of Stomatology, Cancer Research Centre
来源
Virchows Archiv | 2008年 / 452卷
关键词
Oral mucosal melanoma; C-kit mutation; Immunohistochemistry;
D O I
暂无
中图分类号
学科分类号
摘要
C-kit is a trans-membrane receptor tyrosine kinase (RTK) encoded by the proto-oncogene KIT located at 4q11-12. Gain-of-function mutations arising to c-kit activation independent of its ligand were observed in various tumors related to germ cells, mast cells, and interstitial cells of Cajal. C-kit also participates in melanocyte development; hence, its involvement in oral mucosal melanoma (OMM) tumorigenesis was investigated. Immunohistochemistry and mutation analysis were performed using 18 cases of human primary OMM. Results revealed 16 cases positive to c-kit protein. Atypical melanocytes expressed c-kit. All in situ components expressed c-kit, but only four cases exhibited intense expression in the invasive component. Missense mutations were observed in four cases, and two of those correlated with increased protein expression. C-kit expression in atypical melanocytes suggests the role of c-kit in the early stage of OMM tumorigenesis. C-kit protein expression correlated with activating mutations indicating the pertinent role of the proto-oncogene KIT in the tumorigenesis of OMM.
引用
收藏
页码:27 / 32
页数:5
相关论文
共 269 条
[1]  
Alexeev V(2006)Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes J Invest Dermatol 126 1102-1110
[2]  
Yoon K(2005)An immunohistochemical evaluation of c-kit (CD-117) expression in malignant melanoma, and results of imatinib mesylate (Gleevec) therapy in three patients Melanoma Res 15 283-285
[3]  
Alexis JB(2004)c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target? Invest Ophthalmol Vis Sci 45 2075-2082
[4]  
Martinez AE(2006)Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis Gastroenterology 130 1573-1581
[5]  
Lutzky J(1997)Oral mucosal melanomas: the WESTOP Banff workshop proceedings. Western Society of Teachers of Oral Pathology Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 672-679
[6]  
All-Ericsson C(2007)Imatinib in melanoma: a selective treatment option based on KIT mutation status? J Clin Oncol 25 e9-1572
[7]  
Girnita L(2002)KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size Am J Pathol 160 1567-4346
[8]  
Muller-Brunotte A(2006)Somatic activation of KIT in distinct subtypes of melanoma J Clin Oncol 24 4340-33
[9]  
Brodin B(2007)Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors Ann Diagn Pathol 11 27-134
[10]  
Seregard S(2007)Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas Pathol Res Pract 203 127-20